Prostate-targeting drug may reduce risk of esophageal and gastric cancer

To remember

  • The use of 5α-reductase inhibitors (5-ARI) was associated with a reduced risk of adenocarcinoma of the esophagus or cardia in obese or diabetic patients.

Why is this important?

  • This is one of the first studies to assess associations between 5-ARI use and the risk of esophageal cancer and gastric cancer.
Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

PRONOS PARIS RMC The football bet of the day for June 28 – Copa Libertadores

US economic data is higher than expected, soothing demand worries that crude oil rose for 2 consecutive days | Anue Juheng

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.